Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

Condition:   Cutaneous Neurofibroma Interventions:   Drug: Kybella;   Device: 980nm laser;   Device: 755nm Alexandrite Laser;   Device: Radiofrequency Sponsors:   Massachusetts General Hospital;   Johns Hopkins University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials